Related Experiment Video
Updated: Aug 30, 2025

19:32
Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
28.6K
Otoacoutic Emission Testing in Preterm and Term Sick Newborns: A Comparative Analysis
Manjari Basu1, Ajoy Kumar Khaowas2, Saumitra Kumar3
1Department of Pediatrics, College of Medicine and JNM Hospital, The West Bengal University of Health Sciences, Kalyani, India.
Summary
Otoacoustic emission (OAE) screening is effective for sick newborns. While comorbidities increase "refer" rates, there
Area of Science:
- Neonatal care
- Audiology
- Pediatric audiology
Background:
- Cochlear hearing loss is a common issue in both term and preterm newborns, stemming from various pathologies.
- Otoacoustic emission (OAE) and auditory brainstem responses are standard newborn hearing screening methods.
- OAE is preferred for its speed, cost-effectiveness, and accessibility compared to auditory brainstem responses.
Purpose of the Study:
- To assess otoacoustic emissions (OAEs) in sick newborns, including both term and preterm infants, across different pathological conditions.
- To determine if there are significant differences in OAE results between term and preterm sick newborns.
- To evaluate the impact of various comorbidities on OAE screening outcomes in sick neonates.
Main Methods:
- A descriptive study was conducted over three months in a tertiary care hospital's Sick Newborn Care Unit (SNCU).
- All sick newborns admitted to the SNCU during the study period underwent otoacoustic emission (OAE) testing.
- Results were analyzed using the Chi-square test (test of independence) to compare term and preterm infants.
Main Results:
- Among 640 sick newborns (184 preterm), 'refer' rates on OAE varied with pathologies like birth asphyxia, septicaemia, hyperbilirubinemia, meningitis, and congenital anomalies.
- The incidence of 'refer' results on OAE testing increased with co-morbidities in both term and preterm infants.
- No statistically significant difference (p=0.85) was found in OAE results between term and preterm sick newborns, despite slightly higher 'refer' rates in preterm infants with comorbidities.
Conclusions:
- Otoacoustic emission (OAE) screening is a viable method for assessing hearing in sick newborns, regardless of gestational age.
- The presence of comorbidities significantly impacts OAE results, leading to higher 'refer' rates in both term and preterm infants.
- Preterm sick newborns do not exhibit a statistically increased incidence of hearing impairment compared to term sick newborns based on OAE results.

